Matches in SemOpenAlex for { <https://semopenalex.org/work/W2533087844> ?p ?o ?g. }
- W2533087844 endingPage "5410" @default.
- W2533087844 startingPage "5403" @default.
- W2533087844 abstract "The autotaxin–lysophosphatidic acid (ATX–LPA) axis has been implicated in several disease conditions including inflammation, fibrosis and cancer. This makes ATX an attractive drug target and its inhibition may lead to useful therapeutic agents. Through a high throughput screen (HTS) we identified a series of small molecule inhibitors of ATX which have subsequently been optimized for potency, selectivity and developability properties. This has delivered drug-like compounds such as 9v (CRT0273750) which modulate LPA levels in plasma and are suitable for in vivo studies. X-ray crystallography has revealed that these compounds have an unexpected binding mode in that they do not interact with the active site zinc ions but instead occupy the hydrophobic LPC pocket extending from the active site of ATX together with occupying the LPA ‘exit’ channel." @default.
- W2533087844 created "2016-10-28" @default.
- W2533087844 creator A5011921757 @default.
- W2533087844 creator A5014927973 @default.
- W2533087844 creator A5015435740 @default.
- W2533087844 creator A5019957363 @default.
- W2533087844 creator A5021361056 @default.
- W2533087844 creator A5022952804 @default.
- W2533087844 creator A5034187579 @default.
- W2533087844 creator A5036148728 @default.
- W2533087844 creator A5038718794 @default.
- W2533087844 creator A5039248131 @default.
- W2533087844 creator A5042573856 @default.
- W2533087844 creator A5045369166 @default.
- W2533087844 creator A5047982869 @default.
- W2533087844 creator A5057465774 @default.
- W2533087844 creator A5058207605 @default.
- W2533087844 creator A5059361532 @default.
- W2533087844 creator A5061490638 @default.
- W2533087844 creator A5068379792 @default.
- W2533087844 creator A5075186496 @default.
- W2533087844 creator A5078259300 @default.
- W2533087844 creator A5078311956 @default.
- W2533087844 creator A5083344565 @default.
- W2533087844 creator A5086883295 @default.
- W2533087844 creator A5088622927 @default.
- W2533087844 date "2016-11-01" @default.
- W2533087844 modified "2023-10-01" @default.
- W2533087844 title "Discovery of potent inhibitors of the lyso phospholipase autotaxin" @default.
- W2533087844 cites W1480379639 @default.
- W2533087844 cites W1671871957 @default.
- W2533087844 cites W1979571079 @default.
- W2533087844 cites W1979859986 @default.
- W2533087844 cites W1999599951 @default.
- W2533087844 cites W2001801206 @default.
- W2533087844 cites W2026620576 @default.
- W2533087844 cites W2036011686 @default.
- W2533087844 cites W2036627927 @default.
- W2533087844 cites W2046351465 @default.
- W2533087844 cites W2094210837 @default.
- W2533087844 cites W2096597075 @default.
- W2533087844 cites W2121733433 @default.
- W2533087844 cites W2131032222 @default.
- W2533087844 cites W2141635293 @default.
- W2533087844 cites W2159623504 @default.
- W2533087844 cites W2166617029 @default.
- W2533087844 cites W2232285664 @default.
- W2533087844 cites W2235523559 @default.
- W2533087844 doi "https://doi.org/10.1016/j.bmcl.2016.10.036" @default.
- W2533087844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27780639" @default.
- W2533087844 hasPublicationYear "2016" @default.
- W2533087844 type Work @default.
- W2533087844 sameAs 2533087844 @default.
- W2533087844 citedByCount "23" @default.
- W2533087844 countsByYear W25330878442017 @default.
- W2533087844 countsByYear W25330878442018 @default.
- W2533087844 countsByYear W25330878442019 @default.
- W2533087844 countsByYear W25330878442020 @default.
- W2533087844 countsByYear W25330878442021 @default.
- W2533087844 countsByYear W25330878442022 @default.
- W2533087844 countsByYear W25330878442023 @default.
- W2533087844 crossrefType "journal-article" @default.
- W2533087844 hasAuthorship W2533087844A5011921757 @default.
- W2533087844 hasAuthorship W2533087844A5014927973 @default.
- W2533087844 hasAuthorship W2533087844A5015435740 @default.
- W2533087844 hasAuthorship W2533087844A5019957363 @default.
- W2533087844 hasAuthorship W2533087844A5021361056 @default.
- W2533087844 hasAuthorship W2533087844A5022952804 @default.
- W2533087844 hasAuthorship W2533087844A5034187579 @default.
- W2533087844 hasAuthorship W2533087844A5036148728 @default.
- W2533087844 hasAuthorship W2533087844A5038718794 @default.
- W2533087844 hasAuthorship W2533087844A5039248131 @default.
- W2533087844 hasAuthorship W2533087844A5042573856 @default.
- W2533087844 hasAuthorship W2533087844A5045369166 @default.
- W2533087844 hasAuthorship W2533087844A5047982869 @default.
- W2533087844 hasAuthorship W2533087844A5057465774 @default.
- W2533087844 hasAuthorship W2533087844A5058207605 @default.
- W2533087844 hasAuthorship W2533087844A5059361532 @default.
- W2533087844 hasAuthorship W2533087844A5061490638 @default.
- W2533087844 hasAuthorship W2533087844A5068379792 @default.
- W2533087844 hasAuthorship W2533087844A5075186496 @default.
- W2533087844 hasAuthorship W2533087844A5078259300 @default.
- W2533087844 hasAuthorship W2533087844A5078311956 @default.
- W2533087844 hasAuthorship W2533087844A5083344565 @default.
- W2533087844 hasAuthorship W2533087844A5086883295 @default.
- W2533087844 hasAuthorship W2533087844A5088622927 @default.
- W2533087844 hasConcept C150903083 @default.
- W2533087844 hasConcept C161624437 @default.
- W2533087844 hasConcept C170493617 @default.
- W2533087844 hasConcept C185592680 @default.
- W2533087844 hasConcept C202751555 @default.
- W2533087844 hasConcept C207001950 @default.
- W2533087844 hasConcept C2776661833 @default.
- W2533087844 hasConcept C2777752112 @default.
- W2533087844 hasConcept C2780035454 @default.
- W2533087844 hasConcept C37547375 @default.
- W2533087844 hasConcept C55493867 @default.
- W2533087844 hasConcept C74187038 @default.